Heidi Overton, President Donald Trump’s nominee to lead the U.S. Food and Drug Administration, is set to face scrutiny at a U.S. Senate confirmation hearing. Multiple outlets report that senators expect to raise questions tied to two highly contentious public health and policy issues: vaccines and the abortion pill.
The reporting indicates that Republican Sen. Bill Cassidy and other senators plan to press Overton on how the FDA would handle matters related to vaccine oversight and safety, as well as the agency’s role in regulation and access connected to the abortion pill. The coverage frames the hearing as an opportunity for senators to test the nominee’s positions and priorities before a final vote.
While the outlets align on the topics expected to come up, they differ mainly in emphasis and scope. One account highlights the expected scrutiny on both vaccines and the abortion pill at Overton’s confirmation hearing, while another similarly foregrounds the vaccine and abortion-pill lines of questioning.
